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Reply 
We appreciate Fontaine's interest in our recent article (1). His 
comments provide an opportunity to clarify certain aspects concerning 
the pathophysiology of the syndrome of right bundle branch block 
(RBBB), fight precordial ST segment elevation and sudden death. Our 
study (1) thoroughly investigated a family affected by the syndrome. As 
Fontaine points out, the proband's clinical findings were anticipated in
a previous report from our group that addressed ventricular fibrillation 
without apparent heart disease (2). Compared with the previous 
electrocardiogram (ECG), the one shown in the more recent report 
was recorded later, during the clinical follow-up eriod, and showed a
more accentuated right precordial ST segment elevation. Of note, it 
was recorded while the patient was taking beta-antiadrenergic drugs. 
Differences with time in the ST segment elevation pattern, spontane- 
ous or induced by pharmacologic interventions, have been previously 
reported in this syndrome (3,4). ST segment elevation is characteris- 
tically enhanced by vagal maneuvers or class I antiarrhythmic agents 
and reduced after beta-adrenergic stimulation. These responses have 
been explained by postulating a local right ventricular (RV) "depolar- 
ized" area, which results in changes of ST segment elevation after the 
above interventions (4). This is even consistent with our hypothesis 
that RBBB and ST segment elevation are due to a double RV 
conduction defect, both "septal" and "parietal," which may be modu- 
lated by autonomic influences and antiarrhythmic drugs. 
With regard to the structural changes of the RV wall, they 
resembled those observed in the "fatty pattern" of RV cardiomyopa- 
thy, with predominant fatty replacement and without inflammatory 
infiltrates or significant left ventricular lesions (5). However, the 
coexistence ofa severe and progressive (as suggested by the lengthen- 
ing of the PR interval in the more recent ECG) disease of the 
specialized conduction system with RBBB interruption, raises ome 
concerns about he nosography ofthe condition. As recently reported, 
the conduction system issubstantially spared by the dystrophic process 
of the RV cardiomyopathy but is affected at the advanced stage of the 
disease, secondary to the septal involvement (6). In our family, there 
was evidence that the structural changes of RV myocardium and 
conducting tissue may have been inherited together in the setting of a 
"heritable cardiac conduction and myocardial disease" (7). Further 
studies of linkage analysis and gene mapping are needed to better 
characterize the genetic background of the syndrome. 
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